Evidence map›Paper›PMID 41003153›Full record

ReviewMedical sciences (Basel, Switzerland)2025

Unmasking Left Ventricular Diastolic Dysfunction: Pathophysiology, Diagnosis, and Treatment Strategies.

Konstantina Vlasopoulou, Andreas Synetos, Nikolaos Ktenopoulos, Odysseas Katsaros, Leonidas Koliastasis, Anastasios Apostolos, Maria Drakopoulou, Konstantinos Toutouzas, Constantinos Tsioufis

Abstract readReview
In one paragraph

Review in Medical sciences (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Konstantina VlasopoulouFirst Department of Cardiology, Hippokration General Hospital of Athens, National and Kapodistrian University of Athens, 11527 Athens, Greece.ORCID 0009-0002-3437-3780
Andreas SynetosFirst Department of Cardiology, Hippokration General Hospital of Athens, National and Kapodistrian University of Athens, 11527 Athens, Greece.ORCID 0000-0001-8516-1177
Nikolaos KtenopoulosFirst Department of Cardiology, Hippokration General Hospital of Athens, National and Kapodistrian University of Athens, 11527 Athens, Greece.ORCID 0000-0002-0995-7015
Odysseas KatsarosFirst Department of Cardiology, Hippokration General Hospital of Athens, National and Kapodistrian University of Athens, 11527 Athens, Greece.ORCID 0000-0002-7684-3245
Leonidas KoliastasisFirst Department of Cardiology, Hippokration General Hospital of Athens, National and Kapodistrian University of Athens, 11527 Athens, Greece.ORCID 0000-0002-7966-9174
Anastasios ApostolosFirst Department of Cardiology, Hippokration General Hospital of Athens, National and Kapodistrian University of Athens, 11527 Athens, Greece.ORCID 0000-0003-2616-7952
Maria DrakopoulouFirst Department of Cardiology, Hippokration General Hospital of Athens, National and Kapodistrian University of Athens, 11527 Athens, Greece.
Konstantinos ToutouzasFirst Department of Cardiology, Hippokration General Hospital of Athens, National and Kapodistrian University of Athens, 11527 Athens, Greece.
Constantinos TsioufisFirst Department of Cardiology, Hippokration General Hospital of Athens, National and Kapodistrian University of Athens, 11527 Athens, Greece.ORCID 0000-0002-7636-6725

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Left ventricular diastolic dysfunction (LVDD) is characterized by impaired ventricular relaxation and increased chamber stiffness during diastole, resulting in increased left ventricular filling pressures. It represents a highly prevalent yet frequently underdiagnosed cardiac condition with significant clinical implications, serving as a major contributor to heart failure with preserved ejection fraction (HFpEF), particularly among elderly individuals and those with hypertension, diabetes mellitus, obesity, or coronary artery disease. Multiple studies have identified the progression of LVDD as a marker of adverse prognosis, associated with increased morbidity and mortality, highlighting the importance of early recognition and targeted therapeutic strategies to improve diastolic function and clinical outcomes. This review summarizes the pathophysiology, current diagnostic strategies, and treatment options for LVDD, emphasizing its importance in clinical practice.

Indexed as

Ventricular Dysfunction, LeftDiastoleHumansPrognosisStroke Volumediastolic dysfunctionechocardiographyheart failureheart failure with preserved ejection fractionHFpEFleft ventricular diastolic dysfunctionstrain imagingtissue Doppler

Identifiers

PMID41003153
PMCPMC12471323

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.